Breaking News
November 19, 2017 - Dental filling failure linked to smoking, drinking and genetics
November 19, 2017 - Medicaid expansion takes a bite out of medical debt
November 19, 2017 - Study aims to involve parents in early intervention services for children with autism
November 19, 2017 - Don’t Fret Delays in Treating Colon Cancer, Study Suggests
November 19, 2017 - Yeast Infection Test: MedlinePlus Lab Test Information
November 19, 2017 - Video of blood clot contraction reveals how platelets naturally form unobtrusive clots
November 19, 2017 - UNN researchers explore modeling of cognitive dissonance phenomenon
November 19, 2017 - Verseon presents second anticoagulation candidate for clinical trials at AHA 2017
November 19, 2017 - Pregnant Asian women who develop high blood pressure at highest risk for heart failure hospitalization
November 19, 2017 - Medicare seeks comment on ways to cut costs of Part D drugs
November 19, 2017 - Tree cover linked to fewer asthma cases in polluted urban neighborhoods
November 19, 2017 - Make the Diagnosis: Hair Care Conundrum
November 19, 2017 - New techniques give blood biopsies greater promise
November 19, 2017 - Researchers identify possible genetic basis for coronary artery disease
November 19, 2017 - Stress experienced by emergency call handlers has negative impact on psychological health
November 18, 2017 - New cancer cell screening is improving childhood leukaemia treatment
November 18, 2017 - Groundbreaking study identifies protein as potential factor in cancer metastasis
November 18, 2017 - New model to test effectiveness of existing and potential CF therapies
November 18, 2017 - Staying Active May Lower Odds for Glaucoma
November 18, 2017 - Potential new autism drug shows promise in mice
November 18, 2017 - Some states roll back ‘retroactive Medicaid,’ a buffer for the poor — and for hospitals
November 18, 2017 - Selectively deleting stem cell factor promotes recovery after TBI in mice
November 18, 2017 - Breakthrough research brings new procedure closer to helping patients with blood cancer
November 18, 2017 - Dr Peter Simpson Appointed to SLAS Board of Directors
November 18, 2017 - Friendships between young children can protect against ADHD
November 18, 2017 - Old World monkeys could hold key to stop progression of rheumatoid arthritis
November 18, 2017 - Harris Health System RNs named among 20 Outstanding Nurses for 2017
November 18, 2017 - Old World monkeys could be key to a new, powerful rheumatoid arthritis therapy
November 18, 2017 - Mount Sinai researchers identify new therapeutic target for ER+ breast cancer
November 18, 2017 - Age, CRP levels predict success in tapering of biologics in rheumatoid arthritis patients
November 18, 2017 - New dye could be used to observe electrical activity of neurons in the brain
November 18, 2017 - New study further validates use of vaginal progesterone to decrease risk of preterm birth
November 18, 2017 - Russian researcher determined range of reference values for boron in the human body
November 18, 2017 - ‘What the Health?’ Tax bill or health bill?
November 18, 2017 - Could Your Cat Give You ‘Bird Flu?’
November 18, 2017 - Vitamin D Linked to Fertility Outcomes in ART
November 18, 2017 - Neuroscientists identify genetic changes in microglia in a mouse model of neurodegeneration and Alzheimer’s disease
November 18, 2017 - Tax reform proposal could impact care for older Americans
November 18, 2017 - PCSK9 inhibitor offers clinical benefit to patients with peripheral artery disease
November 18, 2017 - Researchers receive £1.3 million to develop sight-saving imaging technology
November 18, 2017 - Novel buckypaper sensor could pave way for high-performance, affordable wearable technology
November 18, 2017 - Despite ACA cost protections, most adolescents skip regular checkups
November 18, 2017 - Stem cell treatment allows paraplegic rats to walk and regain sensory perception
November 18, 2017 - HTC analytical conference comes to the UK
November 18, 2017 - Face It: Drinking, Smoking Takes Toll on Looks: MedlinePlus Health News
November 18, 2017 - New research shows where in the brain the earliest signs of Alzheimer’s occur
November 18, 2017 - Philips announces launch of global movement to raise awareness for COPD
November 18, 2017 - University of Bristol awarded grant to reduce antibacterial drug resistance in Thailand
November 18, 2017 - New oxytocin chemical sensor could be first step towards early diagnosis of autism
November 18, 2017 - Study shows how naïve T-cells may affect tumor immunity and immunotherapy
November 18, 2017 - New studies highlight importance of cardiorespiratory fitness to reduce CVD risk
November 18, 2017 - Study finds medical cannabis is effective at reducing opioid addiction
November 18, 2017 - Specially tailored, ultrafast light pulses can trigger neurons to fire in different patterns
November 18, 2017 - Decrease in sunshine linked to rising incidence of Rickets
November 18, 2017 - Harnessing social media big data to fight against prescription drug crisis
November 18, 2017 - Researchers find way to switch tumor cells between 2D and 3D morphology
November 18, 2017 - Leaf-eating ability of beetle largely due to bacteria inside the insect
November 18, 2017 - FDA Approves Hemlibra (emicizumab-kxwh) for Hemophilia A with Inhibitors
November 18, 2017 - Adolescents underreport amphetamine use, likely unaware that adderall is amphetamine
November 18, 2017 - Study reveals a reduced risk of teenage eczema in breastfed babies
November 18, 2017 - Separating side effects could pave way for safe, effective pain medications
November 18, 2017 - Gut bacteria at young age can contribute to MS disease onset and progression, study suggests
November 18, 2017 - Environmental triggers may play role in development of Lupus
November 18, 2017 - Review looks into conventional versus new treatment modalities in orthodontic pain management
November 17, 2017 - FDA Alert: Diphenoxylate Hydrochloride and Atropine Sulfate Tablets by Greenstone: Recall
November 17, 2017 - For older women, every movement matters
November 17, 2017 - Talking-based therapy could transform aftercare for cancer survivors
November 17, 2017 - Olympus IXplore SpinSR10 imaging system enables researchers to observe fine details in live cells
November 17, 2017 - Study explores reasons for underrepresentation of minorities in genetic cancer research
November 17, 2017 - California firm running physician practices is closing down as scrutiny ramps up
November 17, 2017 - BMI not valid measure of obesity in postmenopausal women, study shows
November 17, 2017 - Vaginal progesterone decreases the risk of premature birth in women with short cervix
November 17, 2017 - Pricey ER Tests for Chest Pain Often Unnecessary
November 17, 2017 - ‘Old’ Lungs May Be Good Transplant Options: MedlinePlus Health News
November 17, 2017 - How not to gain weight over the holidays
November 17, 2017 - Researchers map first-ever proteome of healthy human heart
November 17, 2017 - Drug used to prevent and treat malaria may also be effective for Zika virus
November 17, 2017 - One in 20 children still receiving codeine to treat pain despite warning from federal regulators
November 17, 2017 - Improving clinical trials with machine learning
November 17, 2017 - Experts identify mental exercise program that can reduce risk of dementia
Dear drug using up Medicare expenditures with out proof of better efficacy

Dear drug using up Medicare expenditures with out proof of better efficacy

image_pdfDownload PDFimage_print

Medicare spent greater than $1 billion over a five-year duration on a high-priced drug that has no longer been confirmed more practical for a number of inflammatory prerequisites than a lot more economical corticosteroids, analysis by means of the OHSU/OSU School of Pharmacy presentations.

The research additionally signifies relatively small staff of “common prescribers” mix to put in writing prescriptions that result in the majority of Medicare’s expenditures at the drug, repository adrenocorticotropin, or ACTH.

In 2015 on my own, Medicare spending crowned $500 million at the drug, the price of which has soared to $36,000 in line with process treatment.

Recognized by means of the industry identify H.P. Acthar Gel, steadily shortened to simply Acthar, the drug’s number one use is to regard uncommon epileptic spasms in kids beneath age 2.

“The drug has an enchanting again tale,” stated Dan Hartung, lead creator on a analysis letter that used to be revealed as of late in JAMA Inside Medication. “It is a rather outdated drug, first authorized in 1952, previous to most of the FDA laws about scientific efficacy. The bar for what constitutes authorized indications used to be a lot other then, a lot decrease; it has many indications that got here ahead of the present laws have been set in stone within the 1960s.”

The drug, categorized as a “biologic,” used to be to start with authorized for a huge vary of corticosteroid-responsive inflammatory prerequisites.

“It is a hormone produced within the human frame that alerts the discharge of steroids,” Hartung stated. “It does the similar activity as cheap corticosteroids. And it in point of fact wasn’t a lot on somebody’s radar till 2007.”

Questcor Prescribed drugs bought the rights to the in large part forgotten Acthar in 2001 for $100,000 and started often elevating Acthar’s value. In 2007 Questcor greater the cost of the drug, which as soon as bought for $40 for a vial, or process treatment, from $1,650 to $23,000 in a single day.

Questcor, got by means of Mallinckrodt Prescribed drugs in 2017, markets the drug aggressively for slightly not unusual prerequisites comparable to rheumatoid arthritis, a couple of sclerosis and nephrotic syndrome, Hartung stated. The Meals and Drug Management authorized Acthar for the ones sorts of prerequisites a long time in the past when necessities have been much less strict; no scientific trials have been required.

“There are a selection of FDA-approved indications that lack numerous proof that Acthar is even efficient, let on my own higher than reasonably priced corticosteroids,” Hartung stated. “And what lets in for this sort of pricing is that it is a rather complicated molecule and no competition can precisely replica it; they have got a monopoly in this specific molecule.”

In 2015, Acthar generated gross earnings of about $1 billion – greater than part of which got here from Medicare, and far of the remainder coming from Medicaid, Hartung stated, which means public expenditures most probably accounted for just about all the gross sales.

Hartung and the opposite collaborators discovered Medicare spending at the drug greater tenfold and totaled $1.three billion from 2011 to 2015.

In 2014, a complete of one,621 prescribers have been liable for $391.2 million in Acthar spending; amongst the ones, 203 common prescribers – 94 rheumatologists, 55 neurologists and 54 nephrologists, each and every with greater than 10 prescriptions – accounted for $165 million of the entire.

“And on the whole those physicians are prescribing about the similar collection of different medicine in comparison to their peer uniqueness teams, so we suspect they aren’t treating extra significantly unwell sufferers,” Hartung stated. “Mallinckrodt is in point of fact aggressively advertising and marketing in ways in which perhaps topic prescribers to conflicts of pastime. From the payer facet, there may be in point of fact little that little justifies this drug and its exorbitant price over a lot inexpensive choices. If Medicare have been to take a company stand on reimbursements, this would not be going down.”

Discover additional:
Mallinckrodt purchasing Questcor for approximately $five.6B (Replace)

Additional information:
JAMA Inside Medication (2017). DOI: 10.11001/jamainternmed.2017.3631

Magazine reference:
JAMA Inside Medication

Equipped by means of:
Oregon State College

Tagged with:

About author

Related Articles